Therefore, in the process of clinical treatment of such patients, the disease progression can be mastered through regular detection of serum TTR and APOH expressions, and the patients with specific manifestations of the above indicators can be closely monitored to timely take relevant measures to improve the prognosis of CRC patients [27]. Here, TTR is linked to colorectal carcinoma.